Entries by Andre Leu

On #GivingTuesday, we are in Madrid—and Chile.

Some members of our team are in Madrid this week, to help kick off the official COP25 global climate summit. But many of us are in Santiago, Chile. Chile was supposed to host COP25—until mass protests, triggered by social and economic injustices, forced a last-minute change in venue. Rather than abandon our South American allies in the Regeneration Movement, we chose to follow through with plans, initiated early in 2019, for strategy and training sessions to bring regenerative solutions to a country in crisis.

Opinion: Pesticide Safety Unproven (André Leu)

It might surprise you to learn that there is no scientific proof of safety for the majority of the pesticides, additives or chemicals that companies put in our food and our body care and household products. Most are not tested, and when there is testing, it misses the vast majority of diseases at the normal rates at which they occur due to faulty protocols.

Healthy Soils for a Healthy Life — Increasing Soil Organic Matter Through Organic Agriculture

Given that synthetic nitrogen destroys organic matter, the use of these fertilizers should be avoided as they lock farmers into a perpetual dependence on these costly inputs once the organic matter levels have been run down and most of the organic nitrogen forms in the soil have been depleted. Farmers should be encouraged to obtain all their nitrogen from organic sources such as composts, manures, green manures and legumes and build up their organic matter levels.

André Leu on Monsanto/Bayer Trial: Glyphosate Safety in Question

The World Health Organization’s International Agency for Research on Cancer (IARC) gave glyphosate the second-highest classification for cancer: 2A, a probable human carcinogen, in 2015. Despite this, the manufacturer continues to state that its studies and the reviews by regulators show that glyphosate does not cause cancer. The manufacturer and regulators, like the U.S. EPA, will not produce these safety studies, to be reviewed by independent scientists and other stakeholders, as they are considered commercial in confidence.